InvestSMART

Vitasora Health Limited (ASX:VHL)

ALERT: Price-sensitive ASX Announcement for VHL
Current share price for VHL : $0.013 -0.007 (-35%)+
Announcement
Release
30 Apr 2026 10:00AM
Price at Release
$0.020
Full Release
download
Summary
For the quarter ended 31 March 2026, Vitasora Health Limited reported a 24% increase in their Fee-for-Service revenue, alongside a total quarterly revenue increase of 4% in USD terms. The company highlighted significant operational improvements, including a 15% rise in per patient per month revenue and a 35% boost in daily billing productivity. The launch of the vCare platform on 1 April 2026 is expected to reduce operational expenses by USD 1 million annually and reduce Patient SaaS fees by 91%. Vitasora also benefited from CMS reimbursement improvements, which increased revenue per patient and expanded program eligibility. The company is on track to achieve monthly cashflow breakeven by mid-2026, driven by increased patient enrollment and expanded services within existing client relationships.
Key Points
  • 24% growth in Fee-for-Service revenue.
  • 4% increase in total quarterly revenue in USD.
  • Launch of vCare platform to cut operational costs significantly.
  • CMS reimbursement changes improved revenue per patient.
  • Projected monthly cashflow breakeven by mid-2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.